Stock-Based Compensation - Stock Option (Details) $ / shares in Units, $ in Millions |
12 Months Ended | ||
|---|---|---|---|
|
Dec. 31, 2022
USD ($)
item
$ / shares
shares
|
Dec. 31, 2021
USD ($)
$ / shares
shares
|
Dec. 31, 2020
USD ($)
|
|
| Stock options | |||
| Treasury stock, Shares (in shares) | shares | 1,351,024,943 | 1,350,509,249 | |
| Stock awards outstanding (in shares) | shares | 6,274,525 | 1,549,732 | |
| Stock awards weighted-average grant price (in dollars per share) | $ / shares | $ 128 | $ 135 | |
| Stock-based compensation cost | $ 987 | $ 919 | $ 873 |
| Stock options | |||
| Stock options | |||
| Equal increments | item | 4 | ||
| Contractual term | 10 years | ||
| Anniversaries of the grant date | item | 4 | ||
| Weighted-average fair value | $ / shares | $ 14.29 | ||
| Weighted-average remaining contractual term for options outstanding | 7 years 8 months 12 days | ||
| Options outstanding, total intrinsic value | $ 87 | ||
| Weighted-average remaining contractual term for options vested and exercisable | 3 years 1 month 6 days | ||
| Options vested and exercisable, aggregate intrinsic value | $ 12 | ||
| X | ||||||||||
- Definition Number of anniversaries of grant date in a share based compensation arrangement. No definition available.
|
| X | ||||||||||
- Definition the number of equal increments. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of previously issued common shares repurchased by the issuing entity and held in treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|